News
A newly discovered enzyme is helping scientists perform a rare chemical reaction once considered out of reach, potentially paving the way for a new generation of antibiotics, cancer therapies, and sustainable materials.
By the time Dr Cheng Zhang and his colleagues at AIBN joined CSIRO’s ON Prime program, their PFAS (per- and polyfluoroalkyl substances, or ‘forever chemicals’) sorbent was already showing promise in the lab. What they hadn’t yet figured out was how to make it matter outside of it.
Join The Network
Stay on top of our industry news and developments, events and opportunities, by joining The Network
Meet our researchers
Read nowFollow us
Features
Researchers from The University of Queensland are using synthetic biology to help the world’s biggest businesses transition to net zero.
Work on a new range of hyper accurate cancer drugs has begun with the launch of an Australian-first research and manufacturing hub.
Partner with us
Contact us and learn how our scientific expertise and cutting edge facilities could help you reach your goals.
